Management of loop diuretic resistance in the intensive care unit

American Journal of Health-System Pharmacy

Volumn 66, Issue 18, 2009, Pages 1635-1640

  Asare, Kwame ^a  

^a SAINT THOMAS HOSPITAL   (United States)

Author keywords

Critical illness; Diuretics; Dosage schedules; Drug administration; Edema; Hospitals; Resistance; Toxicity

Indexed keywords

BUMETANIDE; CHLOROTHIAZIDE; ETACRYNIC ACID; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; METOLAZONE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; CLINICAL TRIAL; CONTINUOUS INFUSION; DIURESIS; DRUG BIOAVAILABILITY; DRUG MEGADOSE; DRUG USE; ELECTROLYTE DISTURBANCE; FLUID BALANCE; FLUID RESUSCITATION; HUMAN; HYPERVOLEMIA; HYPOTENSION; INTENSIVE CARE; METABOLIC ALKALOSIS; OTOTOXICITY; PERIPHERAL EDEMA; PLEURA EFFUSION; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION; SODIUM RETENTION;

EID: 70349339648     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp090068     Document Type: Review

References (43)

1. Dellinger RP, Mitchell ML, Carlet JM et al. Surviving sepsis campaign: international guidelines for the management of severe sepsis and septic shock. Crit Care Med. 2008; 36:296-327.
2. Bagshaw SM, Delaney A, Jones D et al. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol. 2007; 156:236-249
3. Uchimo S, Doig GS, Bellomo R et al. Diuretics and mortality in the acute renal failure. Crit Care Med. 2004; 32:1669-1677 (Pubitemid 39050516)
4. Ellison DH. The physiologic basis of diuretic synergism: its role in treating diuretic resistance. Ann Intern Med. 1991; 114:886-894
5. Ellison DH, Velazquez H, Wright FS. Adaptation of the distal convoluted tubule of the rat. Structural and functional effects of dietary salt intake and chronic diuretic infusion. J Clin Invest. 1989; 83:113-126 (Pubitemid 19048413)
6. Kassling B, Bachman S, Kriz W. Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Physiol. 1985; 248:F374-81. (Pubitemid 15142307)
7. Sica DA, Gehr TW. Diuretic combinations in refractory edema states: pharmacokinetic-pharmacodynamic relationships. Clin Pharmacokinet. 1996; 30:229-249 (Pubitemid 126425347)
8. Braile GR, Grennan A, Waldek S. Bioavailability of bumetanide in grossly edematous patients. Clin Pharmacokinet. 1987; 12:440-443
9. Wilcox CS, Mitch WE, Kelly RA et al. Response of the kidney to furosemide: effects of salt intake and renal compensation. J Lab Clin Med. 1983; 102:450-458
10. Vasko MR, Brown-Cartwright D, Knochel JP et al. Furosemide absorption is altered in decompensated congestive heart failure. Ann Intern Med. 1985; 102:314-318 (Pubitemid 15101859)
11. Pivac N, Rumboldt Z, Sardelic S et al. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Int J Clin Pharmacol Res. 1998; 18:121-128 (Pubitemid 28499448)
12. Lahav M, Regev A, Ra'anani P et al. Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest. 1992; 102:725-731
13. Martin SJ, Danziger LH. Continuous infusion of loop diuretics in the critically ill: a review of the literature. Crit Care Med. 1994; 22:1323-1329
14. Rudy DW, Voelker JR, Greene PK et al. Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. Ann Intern Med. 1991; 115:360-366
15. Singh NC, Kisson N, Al Mofada S et al. Comparison of continuous versus intermittent furosemide administration in postoperative pediatric cardiac patients. Crit Care Med. 1992; 20:17-21.
16. Krasna MJ, Scott GE, Scholz PM et al. Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy. Chest. 1986; 89:294-295
17. Dormans TP, van Meyel JJ, Gerlag PG et al. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol. 1996; 28:376-382
18. Wilbur RL, Riemersma LJ. Comparison of furosemide administration by bolus or constant infusion in critically ill patients. Paper presented at ASHP Midyear Clinical Meeting. Las Vegas, NV; 1990 Dec.
19. Kramer WG, Smith WB, Ferguson J et al. Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure. J Clin Pharmacol. 1996; 36:265-270 (Pubitemid 26117027)
20. Amiel SA, Blackburn AM, Reubens RD. Intravenous infusion of furosemide as treatment for ascites in malignant disease. Br Med J. 1984; 288:1041.
21. Osterman M, Alvarez G, Sharpe MD et al. Furosemide administration in critically ill patients by continuous compared to bolus therapy. Nephron Clin Pract. 2007; 107:c70-6.
22. Schuller D, Lynch JP, Fine D. Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med. 1997; 25:1969-1975
23. Copeland JG, Campbell DW, Plachetka JR et al. Diuresis with continuous infusion of furosemide after cardiac surgery. Am J Surg. 1983; 146:796-799
24. Brater DC. Diuretic therapy. N Engl J Med. 1998; 339:387-395
25. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int. 1989; 36:682-689
26. Brater DC, Pressley RH, Anderson SA. Mechanisms of the synergistic combination of metolazone and bumetanide. J Pharmacol Exp Ther. 1985; 233:70-4.
27. Wollam GL, Tarazi RC, Bravo EL et al. Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia. Am J Med. 1982; 72:929-938
28. Ghose RR, Gupta SK. Synergistic action of metolazone with loop diuretics. Br Med J. 1981; 282:1432-1433 (Pubitemid 11096245)
29. Wang D, Gottlieb SS. Diuretics: still the mainstay of treatment. Crit Care Med. 2008; 36(suppl):S89-94.
30. Knauf H, Mutschier E. Sequential nephron blockade breaks resistance to diuretics in edematous states. J Cardiovasc Pharmacol. 1997; 29:367-372 (Pubitemid 27194723)
31. Fliser D, Schroter M, Neubeck M et al. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with renal failure. Kidney Int. 1994; 46:482-488 (Pubitemid 24253057)
32. Dargie HJ, Allison ME, Kennedy AC et al. High dosage metolazone in chronic renal failure. Br Med J. 1972; 4:196-198
33. Rose BD. Diuretics. Kidney Int. 1991; 39:336-352
34. Gonzalez G, Arancibia A, Rivers MI et al. Pharmacokinetics of furosemide in patients with cirrhosis. Eur J Clin Pharmacol. 1982; 22:315-320
35. Gottlieb SS, Khata M, Wentworth D et al. The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and bumetanide in patients with heart failure. Am J Med. 1998; 104:533-538 (Pubitemid 28328765)
36. Oyster JR, Epstein M, Smoker S. Combined therapy with thiazide type and loop diuretic agents for resistant sodium retention. Ann Intern Med. 1983; 99:405-406 Editorial.
37. Sheffield PA, Turner JS Jr. Ototoxic drugs: a review of clinical aspects, histopathologic changes and mechanisms of action. South Med J. 1971; 64:359-363
38. Beermann B, Dalen E, Lindstrom B et al. On the fate of furosemide in man. Eur J Clin Pharmacol. 1975; 9:51-61.
39. Vangish T, Benjamin R, Shenkman L. Deafness from furosemide. Ann Intern Med. 1970; 72:761.
40. Van Meyel JJ, Smits P, Dormans T et al. Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J Intern Med. 1994; 235:329-334 (Pubitemid 24210843)
41. Strom BL, Schinnar R, Apter AJ et al. Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med. 2003; 349:1628-1635 (Pubitemid 37288569)
42. Uchida T, Yamanaga K, Nishikawa M et al. Anti-aldosteronergic effect of torsemide. Eur J Pharmacol. 1991; 205:145-150
43. Blose JS, Adams KF Jr, Patterson JH. Torsemide: a pyridine-sulfonylurea loop diuretic. Ann Pharmacother. 1995; 29:396-402.